A Phase II study of a histamine H-3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • JARSKOG LF
    • CSERNANSKY JG
    • GOFF DC
    • GREEN MF
    • KANTROWITZ JT
    • KESHAVAN MS
    • LAURELLE M
    • LIEBERMAN JA
    • MARDER SR
    • PROF Paul Maruff
    • MCMAHON RP
    • LOWY MT
    • SEIDMAN LJ
    • PEYKAMIAN MA
    • GROVE RA
    • KEEFE RSE
    • HORRIGAN JP
    • BALL MP
    • BREIER A
    • BUCHANAN RW
    • CARTER CS

Published in

  • Schizophrenia Research

Time

Date/time value

  • 2015

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.schres.2015.01.041

Additional Document Info

Parent Title

  • SCHIZOPHRENIA RESEARCH

Volume

  • 164

Issue

  • 1-3

Publisher

  • Elsevier Science